These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 1939459)
21. Decreased mRNA expression levels of DNA methyltransferases type 1 and 3A in systemic lupus erythematosus. Nawrocki MJ; Majewski D; Puszczewicz M; Jagodziński PP Rheumatol Int; 2017 May; 37(5):775-783. PubMed ID: 28349196 [TBL] [Abstract][Full Text] [Related]
22. Therapy with statins in patients with refractory rheumatic diseases: a preliminary study. Abud-Mendoza C; de la Fuente H; Cuevas-Orta E; Baranda L; Cruz-Rizo J; González-Amaro R Lupus; 2003; 12(8):607-11. PubMed ID: 12945719 [TBL] [Abstract][Full Text] [Related]
23. Shared symptoms in rheumatic diseases: a blessing or a curse? Huizinga TW; Gröndal G Arthritis Rheum; 2009 Sep; 60(9):2547-9. PubMed ID: 19714580 [No Abstract] [Full Text] [Related]
24. Systemic lupus erythematosus and other autoimmune rheumatic diseases: challenges to treatment. Murphy G; Lisnevskaia L; Isenberg D Lancet; 2013 Aug; 382(9894):809-18. PubMed ID: 23972423 [TBL] [Abstract][Full Text] [Related]
25. Single-dose and steady state pharmacokinetics of CSA and two main primary metabolites, AM1 and AM4n in patients with rheumatic/autoimmune diseases. Suchy D; Dostalek M; Perinova I; Brozmanova H; Grundmann M; Vyskocil V; Mayer O Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Sep; 155(3):269-74. PubMed ID: 22286813 [TBL] [Abstract][Full Text] [Related]
26. Analysis of associations between the patterns of global DNA hypomethylation and expression of DNA methyltransferase in patients with systemic lupus erythematosus. Zhu X; Liang J; Li F; Yang Y; Xiang L; Xu J Int J Dermatol; 2011 Jun; 50(6):697-704. PubMed ID: 21595664 [TBL] [Abstract][Full Text] [Related]
27. Genome-wide analysis of histone H3 lysine 4 trimethylation by ChIP-chip in peripheral blood mononuclear cells of systemic lupus erythematosus patients. Dai Y; Zhang L; Hu C; Zhang Y Clin Exp Rheumatol; 2010; 28(2):158-68. PubMed ID: 20483040 [TBL] [Abstract][Full Text] [Related]
28. Bioenergetics of immune cells to assess rheumatic disease activity and efficacy of glucocorticoid treatment. Kuhnke A; Burmester GR; Krauss S; Buttgereit F Ann Rheum Dis; 2003 Feb; 62(2):133-9. PubMed ID: 12525382 [TBL] [Abstract][Full Text] [Related]
29. Nuclear factor-kappa B activity in T cells from patients with rheumatic diseases: a preliminary report. Collantes E; Valle Blázquez M; Mazorra V; Macho A; Aranda E; Muñoz E Ann Rheum Dis; 1998 Dec; 57(12):738-41. PubMed ID: 10070274 [TBL] [Abstract][Full Text] [Related]
30. Identification of distinct gene expression profiles in the synovium of patients with systemic lupus erythematosus. Nzeusseu Toukap A; Galant C; Theate I; Maudoux AL; Lories RJ; Houssiau FA; Lauwerys BR Arthritis Rheum; 2007 May; 56(5):1579-88. PubMed ID: 17469140 [TBL] [Abstract][Full Text] [Related]
31. Immune tolerance therapies for autoimmune diseases: Shifting the goalpost to cure. Sharkey P; Thomas R Curr Opin Pharmacol; 2022 Aug; 65():102242. PubMed ID: 35613504 [TBL] [Abstract][Full Text] [Related]
32. Levels of SC5b--9 complement complex in plasma and synovial fluid of patients with rheumatic disease. Rus V; Malide D; Boloşiu HD; Parasca I; Duţu AL Med Interne; 1990; 28(4):305-10. PubMed ID: 2100875 [TBL] [Abstract][Full Text] [Related]
33. Terminal complement complex in synovial tissue from patients affected by rheumatoid arthritis, osteoarthritis and acute joint trauma. Corvetta A; Pomponio G; Rinaldi N; Luchetti MM; Di Loreto C; Stramazzotti D Clin Exp Rheumatol; 1992; 10(5):433-8. PubMed ID: 1458695 [TBL] [Abstract][Full Text] [Related]
34. Genomic 5-mC contents in peripheral blood leukocytes were independent protective factors for coronary artery disease with a specific profile in different leukocyte subtypes. Deng Q; Huang W; Peng C; Gao J; Li Z; Qiu X; Yang N; Yuan B; Zheng F Clin Epigenetics; 2018; 10():9. PubMed ID: 29410709 [TBL] [Abstract][Full Text] [Related]
35. Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases. Gottenberg JE; Guillevin L; Lambotte O; Combe B; Allanore Y; Cantagrel A; Larroche C; Soubrier M; Bouillet L; Dougados M; Fain O; Farge D; Kyndt X; Lortholary O; Masson C; Moura B; Remy P; Thomas T; Wendling D; Anaya JM; Sibilia J; Mariette X; Ann Rheum Dis; 2005 Jun; 64(6):913-20. PubMed ID: 15550531 [TBL] [Abstract][Full Text] [Related]